Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.

Journal: BMC neurology

Volume: 22

Issue: 1

Year of Publication: 2022

Affiliated Institutions:  Center for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse , , Munich, Germany. Ministry of Health, Kampala, Republic of Uganda. National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania. Department of Neurology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Department of Neurology, Kliniken Ostallgaeu-Kaufbeuren, Kaufbeuren, Germany. Department of Radiology, University Hospital Tuebingen, Tuebingen, Germany. Department of Mental Health, University of Gulu, Gulu, Uganda. Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. National Epilepsy Association Malawi, International Bureau of Epilepsy, Lilongwe, Malawi. Department of Infectious Disease Epidemiology, Imperial College London, London, UK. Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany. Center for Global Health, Department of Neurology, School of Medicine, Technical University of Munich, Ismaninger Strasse , , Munich, Germany. andrea.winkler@tum.de.

Abstract summary 

Epilepsy is one of the most common neurological disorders worldwide. Yet, its treatment gap is large in some areas and especially in sub-Saharan Africa data on clinical, radiological and semiological characteristics, as well as on treatment of persons with epilepsy (PWE) are still scarce.We pooled data from four cross-sectional studies on epilepsy in eastern Africa. Two studies from Malawi and Uganda were community-based; two studies in Tanzania (urban Dar es Salaam and rural Haydom) were hospital-based. Clinical characteristics of PWE were assessed by the same questionnaire. Additionally, data on treatment were collected and computed tomography (CT) scans were performed.Overall, 1179 PWE were included in our analysis (581 (49.3%) female, median age 22 years (IQR 15-32 years)). Up to 25% of the patients had focal onset seizures. Those showed a higher rate of remarkable CT scan findings, with especially post-ischaemic and neurocysticercosis-associated lesions, compared to PWE with generalized onset seizures (35.1% vs. 20%). The majority of the patients experienced tonic-clonic seizures (70-85%). Only 67-78% of PWE received anti-seizure medication (ASM) treatment in the community-based studies, mostly monotherapy with phenobarbital, phenytoin or carbamazepine. Yet, underdosage was frequent and a large proportion of PWE received alternative non-ASM treatment consisting of herbal treatment (up to 83%) and/or scarification (up to 20%).Epilepsy is common in sub-Saharan Africa, often caused by neurocysticercosis or ischaemic strokes. PWE suffer from high seizure rates and subsequent injuries, as well as from socio-economic consequences due to insufficient ASM treatment. This pooled analysis illustrates the need for structural programmes for adequate identification, education, assessment and treatment of PWE in sub-Saharan Africa.

Authors & Co-authors:  Stelzle Dominik D Kaducu Joyce J Schmidt Veronika V Welte Tamara M TM Ngowi Bernard J BJ Matuja William W Escheu Gabrielle G Hauke Peter P Richter Vivien V Ovuga Emilio E Pfausler Bettina B Schmutzhard Erich E Amos Action A Harrison Wendy W Keller Luise L Winkler Andrea S AS

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18: 357–75. 10.1016/s1474-4422(18)30454-x.
Authors :  16
Identifiers
Doi : 321
SSN : 1471-2377
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Epilepsy;Global health;Sub-Saharan Africa;Treatment gap
Study Design
Cross Sectional Study
Study Approach
Country of Study
Uganda
Publication Country
England